Patent regime and historic developments in India for the life sciences sector

By Arshad Jamil

India has a hard-won reputation as a major producer of generic pharmaceuticals. However, the IP framework around life sciences is evolving, prompting changes within the sector

Enter your details below to log into your account.

Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.

Twitter

27 Jan 2021

@IAM_magazine Over the course of 2021, IAM subscribers will be able to access more world class content than ever before on our pl… https://t.co/8TfEDquc1n Read more

27 Jan 2021

@IAM_magazine China's government weighs in on a low-profile US patent dispute, latest sign of geopolitical IP tensions https://t.co/ghCyBkxARb Read more

26 Jan 2021

@IAM_magazine In its big-ticket licensing fight with Ericsson, Samsung has filed its first challenges at the PTAB but its move sh… https://t.co/6EMSSfyDgh Read more

26 Jan 2021

@IAM_magazine Allergan’s Botox trade secrets win at the ITC win underlines the commission's growing importance in life sciences I… https://t.co/1zjhfn9Ebf Read more

Find an expert

Andreas Wildhack

Senior Partner

Vienna, Austria

Wildhack & Jellinek

View full biography

Patent regime and historic developments in India for the life sciences sector

Returning user?

Want to read more?

TAGS

Twitter

Find an expert